A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.
Clinical trial NCT02425826 · COMPLETED
Trial details
- NCT number
- NCT02425826
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-20
- Primary completion
- 2016-02-12
- Enrollment
- 221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.